Page last updated: 2024-10-25

ciprofloxacin and Methemoglobinemia

ciprofloxacin has been researched along with Methemoglobinemia in 1 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Methemoglobinemia: The presence of methemoglobin in the blood, resulting in cyanosis. A small amount of methemoglobin is present in the blood normally, but injury or toxic agents convert a larger proportion of hemoglobin into methemoglobin, which does not function reversibly as an oxygen carrier. Methemoglobinemia may be due to a defect in the enzyme NADH methemoglobin reductase (an autosomal recessive trait) or to an abnormality in hemoglobin M (an autosomal dominant trait). (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Srivastava, S1
Srivastava, SK1
Shukla, A1
Chauhan, PM1
Puri, SK1
Bhaduri, AP1
Pandey, VC1

Other Studies

1 other study available for ciprofloxacin and Methemoglobinemia

ArticleYear
Synthesis and methemoglobin toxicity of the amides of 6/7 mono or disubstituted quinolone.
    Bioorganic & medicinal chemistry letters, 1999, Jan-04, Volume: 9, Issue:1

    Topics: Amides; Animals; Anti-Infective Agents; Ciprofloxacin; Cytochrome-B(5) Reductase; Dogs; Dose-Respons

1999